Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting

Abstract

An increase in patient copayments was associated with reductions in a clinic's drug expenditures and prescription drug utilization per visit. Removal of prescription drug samples had no effect except increasing patients' out-of-pocket drug costs.